Cybin Inc Asset Resilience Ratio

Latest as of December 2022: 0.21%

Cybin Inc asset resilience ratio. Cybin Inc (CYBN) has an Asset Resilience Ratio of 0.21% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Cybin Inc to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CA$125.00K

≈ $90.42K USD Cash + Short-term Investments

Total Assets

CA$60.69 Million

≈ $43.91 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Cybin Inc (None–None)

Asset resilience ratio of Cybin Inc from None to None. This chart shows how Cybin Inc's Asset Resilience Ratio has changed over time. Read debt load of Cybin Inc for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Cybin Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see CYBN total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$125.00K	0.21%
Total Liquid Assets	CA$125.00K	0.21%

Asset Resilience Insights

Limited Liquidity: Cybin Inc maintains only 0.21% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Cybin Inc Industry Peers by Asset Resilience Ratio

Compare Cybin Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Bavarian Nordic CO:BAVA	Biotechnology	10.83%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Cybin Inc Asset Resilience Ratio by Year (None–None)

Cybin Inc asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for Cybin Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Cybin Inc

NEO:CYBN Canada Biotechnology

Market Cap

$301.37 Million

CA$416.62 Million CAD

Market Cap Rank

#14540 Global

#435 in Canada

Share Price

CA$8.35

Change (1 day)

-27.89%

52-Week Range

CA$7.70 - CA$11.99

All Time High

CA$150.86